Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

516
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
516
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

341
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
341
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

945
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
945
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

507
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
507
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

682
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
682
Survival Tree01:19

Survival Tree

351
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
351

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment.

Pharmaceutical statistics·2025
Same author

Adaptive designs for best treatment identification with top-two Thompson sampling and acceleration.

Pharmaceutical statistics·2023
Same author

Propensity score matching and stratification using multiparty data without pooling.

Pharmaceutical statistics·2022
Same author

Response-adaptive trial designs with accelerated Thompson sampling.

Pharmaceutical statistics·2021
Same author

To use or not to use propensity score matching?

Pharmaceutical statistics·2020
Same author

Covariate adjustment for randomized controlled trials revisited.

Pharmaceutical statistics·2019
Same journal

A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials.

Pharmaceutical statistics·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

A simple, doubly robust, efficient estimator for survival functions using pseudo observations.

Jixian Wang1

  • 1Celgene International Sarl, Boudry, Switzerland.

Pharmaceutical Statistics
|November 3, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a new doubly robust estimator for survival analysis, improving accuracy when adjusting for confounding factors in treatment assignment. The novel method offers greater efficiency and robustness compared to existing techniques.

Keywords:
Kaplan-Meier estimatorcausal inferencedoubly robustinverse probability weightingpseudo observation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.8K

Related Experiment Videos

Last Updated: Jan 1, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.8K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • Nonparametric estimators like Kaplan-Meier are used for survival functions.
  • Adjusting for confounding factors is crucial for valid survival estimation, especially when treatment assignment is dependent on these factors.
  • Common methods like inverse probability weighting and direct adjustment require correctly specified models, which can be challenging.

Purpose of the Study:

  • To propose a novel pseudo-observation-based doubly robust estimator for survival functions.
  • To provide an estimator that is valid even if only one of the treatment allocation or time-to-event models is correctly specified.
  • To offer a more efficient and robust alternative to existing methods for handling confounding in survival analysis.

Main Methods:

  • Development of a pseudo-observation-based doubly robust estimator.
  • Utilizing simulation studies to evaluate the performance of the proposed estimator under various scenarios.
  • Application of the estimator to a real-world data example for practical illustration.

Main Results:

  • The proposed doubly robust estimator demonstrates robustness and improved efficiency compared to inverse probability weighting.
  • The estimator is valid when either the treatment allocation model or the time-to-event model is correctly specified.
  • Simulation results confirm the theoretical advantages of the new approach.

Conclusions:

  • The pseudo-observation-based doubly robust estimator is a reliable and efficient tool for survival analysis with confounding.
  • The method is easily implementable using standard statistical software.
  • This approach offers a valuable advancement for researchers dealing with complex confounding in time-to-event data.